Fifth Third Bancorp’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Fifth Third Bancorp’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-290	Closed	-$22K	–	2392
2018 Q4	$22K	Hold	290	–	–	﹤0.01%	1546
2018 Q3	$23K	Hold	290	–	–	﹤0.01%	1602
2018 Q2	$29K	Sell	290 -290	-50%	-$25.1K	﹤0.01%	1521
2018 Q1	$47K	Buy	+580	New	+$46.9K	﹤0.01%	1361

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

GAM

Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fifth Third Bancorp's CBPO Position: Q1 2019 in Review

Fifth Third Bancorp sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2019, closing a stake of 290 shares — an estimated $22K sold.

Fifth Third Bancorp first reported a position in CBPO in Q1 2018 and held it in 4 quarters. The position peaked at $47K in Q1 2018. 69 funds tracked by Wall St. Rank hold CBPO as of Q1 2019.

Fifth Third Bancorp reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
Fifth Third Bancorp sold 290 China Biologic Products Holdings, Inc. shares in Q1 2019, an estimated $22K.
Fifth Third Bancorp first reported a position in China Biologic Products Holdings, Inc. in Q1 2018 and held it in 4 quarters.
Fifth Third Bancorp's China Biologic Products Holdings, Inc. position peaked at $47K in Q1 2018.
69 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2019.

Based on Fifth Third Bancorp's 13F filing for Q1 2019, filed 14 May 2019.